Tipsheet
What matters at India’s listed companies
Archive / Mid cap / Page 22

Mid cap

Tue · 26 May
5
Concalls · Engineering - Industrial Equipments

Genus Power's Q4 concall adds nothing new to a story the market already knows.

The May 19 earnings call transcript contains no new material beyond what was already disclosed in prior filings and the live discussion. The market has absorbed it.

GENUSPOWER Mid cap 3:54 PM
6
Order Wins · Electric Equipment

Saatvik locks in ₹171 cr solar order, but the counterparty stays in the dark

The win is worth 3.8% of last year's revenue and adds to a 5.89 GW order book. Execution runs to October 2026.

SAATVIKGL Mid cap 3:52 PM
6
Concalls · Restaurants

Travel Food gave contradictory answers on receivables and a key Delhi concession

A ₹2.64bn receivables surge and a wrong concession date overshadowed a strong FY26 results call.

TRAVELFOOD Mid cap 3:48 PM
6
Earnings · Cables

Diamond Power's profit surges 355% in FY26 on power-infrastructure demand

Annual revenue grew 71% to ₹1,910 crore. The year-end order book stood at ₹3,498 crore.

DIACABS Mid cap 3:37 PM
5
Travel Services

Thomas Cook plugs forex into Atlys. No numbers, no commitments.

The distribution tie-up with a visa platform adds a sales channel. The press release gives no financial terms.

THOMASCOOK Mid cap 3:21 PM
6
Earnings · Telecom - Equipment

Black Box's order backlog swells 57% to $792m on US hyperscaler win

Q4 revenue grew 9% but the company's order book is the story. Full-year bookings crossed $1 billion for the first time.

BBOX Mid cap 3:14 PM
6
Earnings · Construction Vehicles

ACE hikes prices 9-12% to fight 22% steel cost jump

Three rounds of price increases are absorbing a 20-22% surge in steel, which makes up 65% of inputs. The company also finalised its Kato Works JV.

ACE Mid cap 3:04 PM
6
Earnings · Chemicals

Jubilant Ingrevia posts highest profit in 14 quarters on volume recovery

Q4 revenue rose 12% as the company navigated Middle East disruptions and commissioned a new agro CDMO plant. Management guides for sequential growth to start FY27.

JUBLINGREA Mid cap 3:00 PM
6
Earnings · Chemicals

Jubilant Ingrevia hits 14-quarter revenue high, guides for more

Q4 sales reached ₹1,179 cr, the highest in three and a half years. Volume drove the growth, not price.

JUBLINGREA Mid cap 3:00 PM
5
Earnings · Telecom - Equipment

Black Box posts ~6% profit growth for FY26, lifts board limit for fresh fundraising

Audited results for Q4 and FY2026 show steady but unspectacular growth. The board has cleared a ₹2,500 crore fundraise envelope, with no terms yet set.

BBOX Mid cap 2:59 PM
5
Earnings · IT - Software

Seshaasai's Q4 transcript is a compliance filing, not news.

The transcript confirms what was already disclosed in the prior concall summary. No new financial data, guidance, or operational updates.

STYL Mid cap 2:55 PM
6
Plastic Products

Responsive Industries chairperson quits. No successor named.

Rishabh Agarwal resigned as chairperson and non-executive director on May 26 for personal reasons. The small-cap PVC maker has already seen profit fall 25%.

RESPONIND Mid cap 2:49 PM
6
Earnings · Cables

Diamond Power profit quadruples. CFO exits in the same filing.

FY26 revenue jumped 74% and net profit surged more than fourfold. The company replaced its whole-time CFO and director within the same announcement.

DIACABS Mid cap 2:47 PM
6
Earnings · Sugar

E.I.D.-Parry books ₹478 cr in charges to shut its sugar refinery

The company swung to a deeper quarterly loss as it quantifies the cost of exiting the refinery business. Full-year profit fell 35% despite 22% revenue growth.

EIDPARRY Mid cap 2:46 PM
5
Earnings · Chemicals

Jubilant Ingrevia's FY26 profit grows 10.6%. The numbers were expected.

A routine annual result. Consolidated profit hits ₹278 crore on a 5% revenue increase. A ₹13 crore one-time charge is the only wrinkle.

JUBLINGREA Mid cap 2:43 PM
6
Earnings · Plastic Products

Responsive Industries' profit drops 25% as PVC margins erode

Consolidated net profit fell to ₹148.4 cr even as revenue held steady at ₹1,394 cr. Standalone profit fell 55%.

RESPONIND Mid cap 2:37 PM
6
Earnings · Sugar

E.I.D. Parry posts ₹340 cr Q4 loss on refinery shutdown charges

Exceptional items of ₹478 crore from the Parry Sugars Refinery exit drove the quarterly loss. For the full year, consolidated profit slumped 35% to ₹570 crore.

EIDPARRY Mid cap 2:36 PM
6
Earnings · Cables

Diamond Power profit surges 4x on cable demand, but CFO exits

FY26 revenue jumped 74% to ₹1,944 cr on strong cable and conductor demand. CFO Samir Naik resigned for personal reasons on the same day the board approved the numbers.

DIACABS Mid cap 2:33 PM
6
Earnings · Plastic Products

Responsive Industries profit drops 25% as PVC margins compress

Consolidated net profit fell to ₹148.4 crore on flat revenue. Standalone profit was hit harder, down 56%.

RESPONIND Mid cap 2:30 PM
6
Earnings · Sugar

Parry's refinery exit costs ₹478 cr. Profit sinks 35% on a 22% revenue jump.

A ₹591 crore guarantee provision for the shuttered refinery drove a ₹478 crore quarterly charge, widening the standalone loss to ₹340 crore.

EIDPARRY Mid cap 2:27 PM
5
Earnings · Retailing

Redtape's FY26 profit grows 32%, but the filing adds nothing new

Audited standalone results show 32.3% PAT growth on 19.6% higher revenue. The numbers were guided and the Rs. 2 dividend was already paid.

REDTAPE Mid cap 2:13 PM
6
Concalls · IT - Software

Cyient's chip arm raises ₹300 cr, pushes breakeven to FY28

EAAA Alternatives puts ₹300 cr into Cyient Semiconductors at a $500M valuation. The unit now targets breakeven in late FY27 or early FY28.

CYIENT Mid cap 1:58 PM
5
Earnings · Retailing

Redtape's FY26 profit grows 32%, final dividend is ₹2 per share

Audited full-year results confirm 19.6% revenue growth and a 32.3% PAT jump. The numbers were already expected.

REDTAPE Mid cap 1:58 PM
6
Earnings · Pharmaceuticals

Shilpa Medicare drops Aflibercept Europe trial, delays alopecia drug

The company shelved a costly European trial for one biologic and pushed back a Phase I for another, even as Q4 FY26 hit record revenue.

SHILPAMED Mid cap 1:51 PM
6
Earnings · Pharmaceuticals

Marksans closes FY26 with record ₹3,033 cr revenue as Q4 UK sales hit all-time high

Full-year profit rose 9.8% to ₹420 crore. The fourth quarter accelerated, with UK sales at a record and Australia/New Zealand revenue doubling sequentially.

MARKSANS Mid cap 1:31 PM